Global Surgical Site Infection Control Market Report: Information by Product (Disinfectants, Surgical Scrubs), Procedure (Cataract Surgery, Caesarean Section), Type of Infection (Superficial Incisional SSI, Deep Incisional SSI)—Global Forecast till 2023
Surgical Site Infection Control Market Analysis
Surgical site infection control market is growing pervasively over the past few years. Rising prevalence of hospital-acquired infections (HAI) and the most common types of HAI, such as surgical site infections and bloodstream infection (BSI) are expected to drive the market growth predominantly.
Surgical site infections (SSI) are critical and sometimes are dangerous, too, which can cost hugely, resulting in higher mortality rates each year. In such a scenario, surgical site infection control becomes crucial. As a result, the surgical site infection control market is witnessing a rising demand. According to Market Research Future (MRFR), the global surgical site infection control market can impressively grow and attain a CAGR of 6.7% during the forecast period of 2018 to 2023.
Wide-spreading awareness of this kind of infection and the availability of novel medications & treatment procedures can propel the growth of the market. Also, improving economic conditions worldwide fuel market growth, enabling access to improved healthcare.
Moreover, technological advances in medical science backed by the substantial investments made in the R&D activities foster market growth excellently.
Conversely, unmet clinical needs alongside the incidents of drug resistance, complications, and side effects occurring during treatments are some of the factors expected to impede the market growth during the forecast period. Nevertheless, increasing government support for research & development would support the growth of the surgical site infection control market.
Global SSI Control Market – Segments
The market report has five dynamics to widen the scope of understanding,
By Product: Manual Reprocessors Solution, Disinfectants (Hand Disinfectants, Skin Disinfectants, Surgical Scrubs, Surgical Drapes, Skin Preparation Solution, Medical Nonwovens, Surgical Gloves, others), and others.
By Procedure: Cataract Surgery, Cesarean Section, Dental Restoration, Gastric Bypass, and others.
By Type of Infection: Superficial Incisional SSI, Deep Incisional SSI, Organ or Space SSI, and others.
By End-user: Ambulatory Surgical Centers, Hospitals, and others.
By Regions: North America, Europe, APAC, and the Rest-of-the-World (RoW).
Global Surgical Site Infection Control Market – Competitive Analysis
Highly competitive, the surgical site infection control market appears to be fragmented, characterized by the presence of several well-established players. To gain a significant market share, players incorporate strategic initiatives such as mergers & acquisitions, collaborations, expansion, and new therapeutics & technology launch.
They invest heavily in R&D and clinical trials to develop effective drugs, focusing on areas with a high unmet medical need, these companies assess areas that require further innovation over the progress that has been made. Substantial investments made by the top players to develop novel therapeutics for these infections, help these players to hold significant market share.
Major Players:
Players leading the global surgical site infection control market, include 3M, Becton Dickinson and Company, Belimed AG, bioMerieux SA, Getinge Group, Johnson & Johnson, Kimberly-Clark Corporation, Sotera Health, Ansell Limited, Steris Corporation, Lac-Mac Limited, Pacon Manufacturing Corp, and American Polyfilm Inc., among others.
Industry/Innovations/Related News:
October 11, 2019 —- 3M, an American multinational conglomerate operating in the fields of industry, worker safety, health care, and consumer goods, announced the completion of Acelity L.P. Inc. (the US), a medical device company and its KCI subsidiaries worldwide. Acelity is one of the leading medical technology company globally.
The acquisition worth approximately USD 6.7 BN would further accelerate 3M’s role as a leader in treating advanced wound care, which is a significant and growing market segment. Recently, on May 16, 2019, had announced receiving the FDA approval for its PREVENA negative pressure incision management system indicated to help with reducing superficial surgical site infections in those at high risk of post-op infections.
October 22, 2019 —- Becton, Dickinson and Company India, a leading medical technology company conducted a program ‘Heal-o-nomics’ conceptualized to apprehend the challenges in preventing hospital-acquired infections (HAIs) to achieve better health outcomes at optimized cost, Including the most common types such as surgical site infections, and bloodstream infection (BSI). Presented studies include the epidemiology and prevention of BSI and the evaluation rates device-associated infections across Indian hospitals. The rising number of HAI in India has led experts to gather and discuss the ways to prevent them.
Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/surgical-site-infection-control-market-7830
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.